Patent details

EP3226894 Title: STABLE LIQUID VACCINIA VIRUS FORMULATIONS

Basic Information

Publication number:
EP3226894
PCT Application Number:
EP2015078239
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP158044073
PCT Publication Number:
WO2016087457
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABLE LIQUID VACCINIA VIRUS FORMULATIONS
French Title of Invention:
FORMULATION STABLE ET LIQUIDE DE VIRUS DE LA VACCINE
German Title of Invention:
STABILE FLÜSSIGE VACCINIA VIRUS ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
01/12/2015
Grant date:
07/08/2019
EP Publication Date:
11/10/2017
PCT Publication Date:
09/06/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/12/2019
Expiration date:
01/12/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
Transgene SA
Address:
Parc d'Innovation Boulevard Gonthier d`Andernach, 67400 Illkirch Graffenstaden, France (FR)

Inventor

Name:
CHASLE, Mélina
Address:
France (FR)

Priority

Priority Number:
14306930
Priority Date:
01/12/2014
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/08; A61K 39/275;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages